Ceribell sues Natus Medical for patent infringement (CBLL) - Seeking Alpha
4 days ago • Google News
CeriBell, Inc (CBLL)
US$ 22.692.12%
Price Chart
Key Statistics
Market Cap
$ 768.07M
P/E Ratio
0.00
Revenue (TTM)
$ 60.04M
Volume
332.41K
52W High
$ 32.75
52W Low
$ 10.01
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
24.6195
200-Day MA
25.5483
52 Week High
32.749
52 Week Low
10.01
About CBLL
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
Employees
281
Headquarters
Sunnyvale, CA
CEO
Dr. Xingjuan Chao Ph.D.
Latest News
Ceribell (CBLL) CEO Chao sells $442,500 in stock By Investing.com - Investing.com South Africa
2 days ago • Google News
Ceribell's IP Offense: How Legal Aggression Could Spark a Neurotech Breakout - AInvest
4 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg